Compare Illumina, Inc. (ILMN) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Newegg Commerce Inc — how do they compare? Illumina, Inc. trades at $190.66 (market cap $27.94B), while Newegg Commerce Inc trades at $13.5 (market cap $270.98M). The key difference: Illumina, Inc. is far larger — about 103.1× Newegg Commerce Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | NEGG | |
|---|---|---|
Market Cap | $27.94B | $270.98M |
Sector | Health | Consumer Cyclical |
52-Week High | $194.33 | $128.09 |
52-Week Low | $91.00 | $12.92 |
Enterprise Value | $29.33B | $269.78M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
NEGG trades at $13.12, up 1.0% today, with a bearish technical outlook despite oversold RSI readings. The company shows improving fundamentals, with Q1 2026 EPS beating expectations and revenue stabilizing near $1.4B, though net margins remain thin at 0.39%. Recent news highlights product launches and AI shopping enhancements, signaling innovation efforts. Cash flow trends are volatile, with 2025 net cash flow positive at $8.91M but 2026 projecting a significant outflow.
The stock presents a mixed outlook: low P/S ratio of 0.19 suggests undervaluation relative to sales, but high P/E of 49.72 and consistent net losses pose risks. Analyst sentiment is bullish with a 100% buy rating, yet technical weakness and competitive e-commerce pressures require caution. Near-term catalysts include execution on profitability and AI initiatives, but investor patience is needed for sustained turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
